Weill Medical College Of Cornell University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1865-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://weill.cornell.edu
Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction
Completed
- Conditions
- ThrombusMyocardial Infarction
- First Posted Date
- 2007-10-03
- Last Posted Date
- 2018-02-14
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 250
- Registration Number
- NCT00539045
- Locations
- 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
Effect of Steroids on Gene Expression in the Healthy Smokers Lungs
Phase 4
Withdrawn
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Drug: Beclomethasone
- First Posted Date
- 2007-09-20
- Last Posted Date
- 2016-05-04
- Lead Sponsor
- Weill Medical College of Cornell University
- Registration Number
- NCT00532584
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
fMRI Investigation of Depression in Patients With Epilepsy
Withdrawn
- Conditions
- EpilepsyDepression
- First Posted Date
- 2007-09-20
- Last Posted Date
- 2009-02-10
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 250
- Registration Number
- NCT00532376
- Locations
- 🇺🇸
Citigroup Biomedical Imaging Center at 516 East 72nd Street, New York, New York, United States
Placement of Permanent Pacemaker Study
Completed
- Conditions
- Cardiac Surgical Procedures
- First Posted Date
- 2007-08-07
- Last Posted Date
- 2017-01-19
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 500
- Registration Number
- NCT00512161
- Locations
- 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL
Phase 2
Completed
- Conditions
- Non-Hodgkin's Lymphoma
- Interventions
- Drug: mesna, cisplatin, etoposide, rituximab
- First Posted Date
- 2007-07-20
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 15
- Registration Number
- NCT00504751
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
- First Posted Date
- 2007-07-20
- Last Posted Date
- 2018-05-29
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 23
- Registration Number
- NCT00504972
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Lung Disease Collection (Qatar): Evaluation of the Lungs of Individuals With Lung Disease
Completed
- Conditions
- AsthmaLung DiseaseChronic Obstructive Pulmonary Disease (COPD)
- First Posted Date
- 2007-07-20
- Last Posted Date
- 2015-04-21
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 75
- Registration Number
- NCT00504738
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Phase 1
Withdrawn
- Conditions
- Esophageal Neoplasms
- Interventions
- Genetic: AdcuCD40LGenetic: Placebo
- First Posted Date
- 2007-07-20
- Last Posted Date
- 2016-05-04
- Lead Sponsor
- Weill Medical College of Cornell University
- Registration Number
- NCT00504322
Combined Agent Randomized Trial of Induction of Labor
Not Applicable
Completed
- Conditions
- Labor InductionCervical Ripening
- First Posted Date
- 2007-07-20
- Last Posted Date
- 2007-07-20
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 210
- Registration Number
- NCT00504465
- Locations
- 🇺🇸
New York Hospital Medical Center of Queens, Flushing, New York, United States
🇺🇸The Brooklyn Hospital Center, Brooklyn, New York, United States
🇺🇸Weill Medical College of Cornell University, New York, New York, United States
Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)
Completed
- Conditions
- Interstitial Lung DiseaseAsthmaCOPDLung CancerCystic Fibrosis
- First Posted Date
- 2007-07-20
- Last Posted Date
- 2016-05-02
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 600
- Registration Number
- NCT00504361
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
© Copyright 2025. All Rights Reserved by MedPath